Skip to main content
. 2022 Aug 15;45(1):371–384. doi: 10.1007/s11357-022-00639-8

Fig. 7.

Fig. 7

Summary of the changes with angiotensin receptor blocker (ARB) treatment in both not cognitively impaired and Alzheimer’s dementia participants. ACE, angiotensin-converting enzyme; Ang, angiotensin; ARB, angiotensin receptor blocker; AP-A, aminopeptidase A; AP-N, aminopeptidase N; AT1R, angiotensin II type 1 receptor; AT2R, angiotensin II type 2 receptor; AT4R, angiotensin type 4 receptor